Arterial hypertension is one of the most common pathologies and is currently acquiring the scale of a pandemic among noncommunicable diseases. This is the most important risk factor for developing cardiovascular diseases and mortality.

Hypertension remains one of the most important causes of chronic heart failure (CHF) in all age groups. According to the Framingham study, among patients with CHF, only 25% had a myocardial infarction as the cause of development, and 75% had hypertension.

How to treat such patients? How to choose a safe and effective treatment strategy?

These questions will be answered in her lecture by practicing cardiologist Maria Cherskaya, candidate of Medical Sciences, head of the consulting and diagnostic Department, State Institution "Komissarenko Institute of Endocrinology and metabolism of NAMNU".

After watching this video, you will learn about the place of hypertension in the development of CHF, find out the mechanisms of CHF development in hypertension, get historical facts about how ACE inhibitors appeared and developed, and analyze the evidence base for enalapril.